Navigation Links
Lapatinib shows minimal effect against liver cancer
Date:9/8/2009

PHILADELPHIA Use of the molecularly targeted agent lapatinib to delay tumor growth and improve the survival of patients with inoperable hepatocellular carcinoma, or liver cancer, only benefited certain subgroups of patients. While results of this study were largely negative, patients that exhibited toxicity from the drug in the form of a skin rash appeared to have a greater tumor response and longer survival.

Findings of this phase II, multi-institutional study are published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

"These results may not be practice changing, but they do emphasize the need to continue developing strategies targeting epidermal growth factor receptor [EGFR] in hepatocellular carcinoma," said lead researcher Tanios Bekaii-Saab, M.D., assistant professor of medicine and pharmacology and medical director of gastrointestinal oncology at the Ohio State University Comprehensive Cancer Center.

The prevalence of hepatocellular carcinoma is increasing worldwide, and since this form of cancer typically responds poorly to chemotherapy, new treatments are necessary to help curb its rise. The current standard treatment for advanced hepatocellular carcinoma is sorafenib.

This study is one of the first trials to test the tolerability and efficacy of lapatinib in patients with advanced hepatocellular carcinoma. Lapatinib targets both EGFR and Human EGFR type 2 (HER2/neu) signaling pathways. The FDA approved this drug in March of 2007 for patients with breast cancer who were already using the chemotherapeutic agent capecitabine. Lapatinib works by inhibiting the tyrosine kinase activity associated with the two oncogenes EGFR and HER2/neu.

Twenty-six patients with advanced hepatocellular carcinoma received 1,500 mg/d of lapatinib by mouth for 28 days. Bekaii-Saab and colleagues evaluated tumor and blood specimens for expression of these signaling pathways. '/>"/>

Contact: Tara Yates
tara.yates@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer
2. GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New research shows how chronic stress worsens neurodegenerative disease course
5. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
6. Circulating fats kill transplanted pancreas cells, study shows
7. New Heart Pump Shows Promise in Trial
8. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
9. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
10. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
11. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lapatinib shows minimal effect against liver cancer
(Date:9/17/2014)... September 17, 2014 ICS Learning Group, ... for Excellence in Training for the Best Use of ... based on an online operational safety training module that ... forklift operation. Using an approach that combined realistic ... module that was similar to a video game, including ...
(Date:9/17/2014)... September 17, 2014 MicroSourcing International, Inc., ... Process Outsourcing (BPO) services in the Philippines, announced today ... Senior Vice President – North America to further develop ... is a 15 year veteran of the offshore outsourcing ... helping companies, ranging in size from small businesses to ...
(Date:9/17/2014)... CA (PRWEB) September 17, 2014 ... high throughput research solutions for drug development, today ... Module 3 (CM3) Reaction Screening System to both ... to the Texas community. Freeslate’s high throughput system ... area of reaction screening and optimization for small ...
(Date:9/17/2014)... Hallandale Beach, FL (PRWEB) September 17, 2014 ... products, is pleased to announce their newest addition to ... This conditioner is formulated with nourishing and beneficial ... jojoba oils to provide hair with ample moisture, while ... Volumizing Biotin Conditioner is formulated to complement the ...
(Date:9/17/2014)... 2014 1st-Dress.com, one of the most ... long bridesmaid dresses recently. All the fresh ... quality materials. Furthermore, they are offered at deeply discounted ... , The firm is striving to provide a ... its workers never compromises on style, quality and customer ...
Breaking Medicine News(10 mins):Health News:ICS Learning Group Wins Gold in the 2014 Brandon Hall Excellence Competition for Best Use of Games and Simulations for Learning 2Health News:MicroSourcing Appoints New Senior Vice President of North America 2Health News:Baylor University Selects Freeslate Reaction Screening System to Support New High Throughput Screening Lab 2Health News:Luxury Barber Adds New Regenepure Biotin Conditioner to Their Selection of Grooming Products 2Health News:2014 Long Bridesmaid Dresses Available Online At 1st-Dress.com 2
... interests and those of the pharmaceutical industry has got sharper ... a bill that would clothe the Food and Drug Administration ... two years before advertising a newly approved drug directly to ... powers to fine companies that fail to do post-approval studies ...
... the most malignant diseases which are responsible for number of ... on this subject. A new study suggests that true biological ... have been confounded by Dr. Tim Byers, of the University ... ,It is not due to the disparity in the access ...
... vigorous arguments never seem to leave the Hormone Replacement Therapy (HRT) ... ‘notoriety’. ,Yet say some experts, don’t be in a ... them, hormone replacement therapy may have led to the deaths of ... 1991. ,In an article said to be the first ...
... pain and agony begin to subside over Monday’s ghastly student massacre ... killer Cho Seung-Hui began to take form. , The ... any stronger than this point of time. At the same time, ... ,The fact that Cho was a ‘disturbed’ student was not ...
... from vegetable sources, is touted as a more eco-friendly fuel, ... use of ethanol could actually pose a threat to human ... that eco-friendly after all. The journey for ever is hitting ... the US shows that it could be damaging to human ...
... small percentage of food imported into the United States is ... of some form or the other. What happens to the ... ,Recently, the United States has been reeling under the effect ... This could also be due to lenient food laws in ...
Cached Medicine News:Health News:Moratorium Proposed on Advertisements of Newly Approved Drugs 2Health News:Expert Warn- Odds Still Stacked Against Hormone Replacement Therapy 2Health News:Expert Warn- Odds Still Stacked Against Hormone Replacement Therapy 3Health News:Virginia Tech. Shooter -Human Rights or Innocent Lives 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 3
(Date:9/16/2014)... , Sept. 16, 2014  Advanced Medical ... stage development company engaged primarily in the ... for diagnostic and therapeutic applications, today announced ... related to its brachytherapy products.  AMIC,s rights ... its license from Battelle, under which AMIC ...
(Date:9/16/2014)... 16, 2014  Formex, LLC ("Formex"), a ... Mr. Greg Weilersbacher joined Formex as Director of ... Greg Weilersbacher has over ... expertise in Quality Assurance, Facility Validation, GMP ... brings to Formex a diverse wealth of ...
(Date:9/16/2014)... , Sept. 16, 2014 On September 25 ... exhibition focusing on medical design and manufacturing - MEDTEC ... Shanghai World Expo Exhibition & Convention Center, bringing together ... and regions to showcase their latest medical-grade raw materials, ... only one week remaining for free visitor pre-registration to ...
Breaking Medicine Technology:Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 4Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4
XL STABI Hydrophilic Acrylic Lens....
TRIPODE Hydrophilic Acrylic Lens....
Biocryl™ Acrylic Foldable Lens....
The STAAR ELASTIMIDE lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
Medicine Products: